BCI Marketplace
Depression Neuromodulation trials

Accelerated TMS for Perinatal Depression

RecruitingNCT06968390Phase: NAStarted 2025-08-05

Summary

We are studying a treatment for depression called accelerated Transcranial Magnetic Stimulation (TMS) among pregnant and postpartum individuals. TMS is a focal, non-invasive form of brain stimulation that is cleared by the Food and Drug Administration for depression. Typically, traditional TMS involves daily treatments for 6-8 weeks. In this study, we will offer an accelerated form of TMS that involves multiple daily treatments for 5 days.

Eligibility

Sex
FEMALE
Min Age
18 Years
Max Age
55 Years

Inclusion Criteria: * Age 18-55 * All individuals must be 14-34 weeks gestational age or within one year of delivery at the time of treatment. The odds of delivery nears 10% after 36 weeks, which would limit participants from being able to complete the study and interfere with the primary study aim

Locations

Brigham and Women's Hospital
Boston, Massachusetts, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →